A Clinical Study of 9MW2821 Monotherapy or Combined With Other Anticancer Therapy in Advanced Solid Tumors
Clinical trial NCT06947226 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06947226
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2026-04-01
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.